Literature DB >> 17059692

Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2).

Quan M Nhu1, Natalia Cuesta, Stefanie N Vogel.   

Abstract

Activation of TLRs is most closely associated with induction of pro-inflammatory gene expression; however, expression of many other genes, including the TLR genes themselves, has also been shown to be modulated following TLR engagement. A large family of nuclear transcription factors, the interferon regulatory factors (IRFs), have been implicated in TLR signaling leading to pro-inflammatory gene expression. Given that IRF-1 and IRF-2 counter-regulate the transcriptional activity of many genes, we hypothesized that IRF-1 and IRF-2 might also regulate TLR gene expression following LPS stimulation of murine macrophages. mRNA derived from medium- or LPS-treated primary peritoneal macrophages was analyzed for TLR gene expression using quantitative real-time PCR. In wild-type macrophages, LPS up-regulated expression of TLRs 1-3 and 6-9 steady-state mRNA, while TLR4 mRNA was modestly down-regulated. IRF-2(-/-) macrophages responded to LPS with dysregulated expression of TLR3, TLR4, and TLR5 mRNA, whereas IRF-1 deficiency dampened LPS-induced mRNA expression for TLR3, TLR6, and TLR9. Functional studies revealed aberrant TLR3 signaling in IRF-2(-/-) macrophages. Collectively, these findings reveal an additional level of complexity associated with TLR transcriptional regulation and suggest that the trans-acting factors, IRF-1 and IRF-2, contribute to the innate immune response to infections by regulating TLR gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17059692      PMCID: PMC5930016          DOI: 10.1179/096805106X118834

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  58 in total

1.  Toll-like receptors are temporally involved in host defense.

Authors:  David S Weiss; Bärbel Raupach; Kiyoshi Takeda; Shizuo Akira; Arturo Zychlinsky
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

2.  Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1.

Authors:  G Senaldi; C L Shaklee; J Guo; L Martin; T Boone; T W Mak; T R Ulich
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

3.  NF-kappa B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression.

Authors:  T Musikacharoen; T Matsuguchi; T Kikuchi; Y Yoshikai
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

4.  Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2.

Authors:  P S Vaughan; C M van der Meijden; F Aziz; H Harada; T Taniguchi; A J van Wijnen; J L Stein; G S Stein
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

5.  Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression.

Authors:  Thierry Roger; Isabelle Miconnet; Anne-Laure Schiesser; Hirofumi Kai; Kensuke Miyake; Thierry Calandra
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

6.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 9.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.

Authors:  Stefanie N Vogel; Katherine A Fitzgerald; Matthew J Fenton
Journal:  Mol Interv       Date:  2003-12

10.  Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Hee Jeong Kong; Akira Nishiyama; Ken J Ishii; Dennis M Klinman; Keiko Ozato
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  30 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  Differential host response to LPS variants in amniochorion and the TLR4/MD-2 system in Macaca nemestrina.

Authors:  J Chang; S Jain; D J Carl; L Paolella; R P Darveau; M G Gravett; K M Adams Waldorf
Journal:  Placenta       Date:  2010-09       Impact factor: 3.481

3.  Self-adjuvanting C18 lipid vinil sulfone-PP2A vaccine: study of the induced immunomodulation against Trichuris muris infection.

Authors:  M Gomez-Samblas; J J García-Rodríguez; M Trelis; D Bernal; F J Lopez-Jaramillo; F Santoyo-Gonzalez; S Vilchez; A M Espino; F Bolás-Fernández; A Osuna
Journal:  Open Biol       Date:  2017-04       Impact factor: 6.411

4.  Exogenous heat shock protein HSP70 modulates lipopolysaccharide-induced macrophage activation.

Authors:  O Yu Antonova; M M Yurinskaya; S Yu Funikov; M B Evgen'ev; M G Vinokurov
Journal:  Dokl Biol Sci       Date:  2013-10-23

Review 5.  Toll-like receptor signaling in endogenous neuroprotection and stroke.

Authors:  B J Marsh; R L Williams-Karnesky; M P Stenzel-Poore
Journal:  Neuroscience       Date:  2008-08-12       Impact factor: 3.590

6.  Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages.

Authors:  Quan M Nhu; Kari Ann Shirey; Meghan E Pennini; Jennifer Stiltz; Stefanie N Vogel
Journal:  Innate Immun       Date:  2011-01-14       Impact factor: 2.680

7.  Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Authors:  C Ricardo-Carter; M Favila; R E Polando; R N Cotton; K Bogard Horner; D Condon; W Ballhorn; J P Whitcomb; M Yadav; R L Geister; J S Schorey; M A McDowell
Journal:  Parasite Immunol       Date:  2013-12       Impact factor: 2.280

8.  Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.

Authors:  Elena Gabrielli; Eva Pericolini; Elio Cenci; Federica Ortelli; Walter Magliani; Tecla Ciociola; Francesco Bistoni; Stefania Conti; Anna Vecchiarelli; Luciano Polonelli
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

9.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo.

Authors:  Q M Nhu; K Shirey; J R Teijaro; D L Farber; S Netzel-Arnett; T M Antalis; A Fasano; S N Vogel
Journal:  Mucosal Immunol       Date:  2009-10-28       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.